
ASTRAZENECA PLC
Aktie · GB0009895292 · 886455 (XLON)
106,68 GBP
Schlusskurs XLON 06.06.2025:
10.770,00 GBX
London · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 17:35
Aktuelle Kurse von ASTRAZENECA PLC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung |
---|---|---|---|---|---|
![]() XETRA |
ZEG.DE
|
EUR
|
06.06.2025 15:35
|
127,95 EUR
| 127,15 EUR
+0,63 %
|
![]() London |
AZN.L
|
GBX
|
06.06.2025 15:14
|
10.770,00 GBX
| 10.688,00 GBX
+0,77 %
|
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
0,00 % | 1,11 % | -0,82 % | -11,62 % | -0,54 % | -15,34 % | 26,15 % |
Profil de l'entreprise pour ASTRAZENECA PLC Action
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Fonds investis
Les fonds suivants ont investi dans : ASTRAZENECA PLC investi :
Fonds | Vol. en millions 4.801,23 | Part (%) 11,00 % |
Fonds | Vol. en millions 8.928,03 | Part (%) 7,25 % |
Fonds | Vol. en millions 8.456,99 | Part (%) 6,75 % |
Fonds | Vol. en millions 116.248,56 | Part (%) 6,75 % |
Fonds | Vol. en millions 235,17 | Part (%) 4,34 % |
Données de l'entreprise
Nom ASTRAZENECA PLC
Société AstraZeneca PLC
Site web
https://www.astrazeneca.com
Marché d'origine
London

WKN 886455
ISIN GB0009895292
Type de titre Action
Secteur Healthcare
Industrie Drug Manufacturers - General
PDG Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.
Capitalisation boursière 184 Mrd.
Pays Royaume-Uni
Devise GBP
Employés 94,3 T
Adresse 1 Francis Crick Avenue, CB2 0AA Cambridge
Date d'introduction en bourse 2003-12-02
Dividendes de 'ASTRAZENECA PLC'
Date ex-dividende | Dividende par action |
---|---|
20.02.2025 | 133,07 GBX |
08.08.2024 | 60,92 GBX |
22.02.2024 | 123,25 GBX |
10.08.2023 | 56,54 GBX |
23.02.2023 | 135,30 GBX |
11.08.2022 | 76,40 GBX |
24.02.2022 | 108,01 GBX |
12.08.2021 | 46,82 GBX |
25.02.2021 | 98,00 GBX |
13.08.2020 | 53,26 GBX |
Symboles boursiers
Nom | Symbole |
---|---|
Frankfurt | ZEG.F |
London | AZN.L |
XETRA | ZEG.DE |
Autres actions
Les investisseurs qui détiennent ASTRAZENECA PLC ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.